Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. (2023)

First Author: Brocklebank V
Attributed to:  Personalised management of atypical haemolytic uraemic syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022018833

PubMed Identifier: 37369098

Publication URI: http://europepmc.org/abstract/MED/37369098

Type: Journal Article/Review

Volume: 142

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971